Open access peer-reviewed Edited Volume

Novel Aspects in Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) has turned from a universally fatal to a highly curable disease in little more than four decades. Even though differences in outcome continue to exist between children and adults, intense efforts are under way to overcome this discrepancy and improve the prognosis of adult patients as well. This exemplary progress in ALL therapy has been possible by the combination of an increasingly better understanding of the biology of the disease, availability of a range of effective drugs, and astute designs and relentless executions of many clinical trials. ALL is a complex disease requiring complex therapy. Whereas this book cannot provide a comprehensive review of every one of its many facets, the chapters from many investigators from around the world nevertheless cover a number of relevant topics: aspects of the epidemiology of ALL in Hispanics, ophthalmologic manifestations of ALL, overviews of current therapy and drug-resistance mechanisms, novel biological pathways and targets, new drugs in development, and long-term consequences of CNS prophylaxis and therapy. The publishers and editor therefore hope that the prospective readers will find enough insight and information for their own endeavors.

Read more >Order hardcopy
IntechOpen
Novel Aspects in Acute Lymphoblastic LeukemiaEdited by Stefan Faderl

Published: November 16th 2011

DOI: 10.5772/1050

ISBN: 978-953-307-753-6

Copyright year: 2011

Books open for chapter submissions

27335 Total Chapter Downloads

2 Crossref Citations

7 Web of Science Citations

18 Dimensions Citations

chaptersDownloads

Open access peer-reviewed

1. Childhood Acute Leukemias in Hispanic Population: Differences by Age Peak and Immunophenotype

By Juan Manuel Mejía-Aranguré, María Luisa Pérez-Saldivar, Rosana Pelayo-Camacho, Ezequiel Fuentes-Pananá, Carolina Bekker-Mendez, Abigail Morales-Sánchez, David Aldebarán Duarte-Rodríguez and Arturo Fajardo-Gutiérrez

1498

Open access peer-reviewed

2. Natural Killer Cell Leukemia: Diagnosis, Pathogenesis and Treatment

By Shoko Kobayashi

1666

Open access peer-reviewed

3. Ophthalmological Manifestations in Acute Lymphoblastic Leukemia

By Javier Mateo, Francisco J. Ascaso, Esther Núñez, Carlos Peiro, Gonzalo González and José A. Cristóbal

8909

Open access peer-reviewed

4. Acute Lymphoblastic Leukemia: What Have We Learned About the Effects of This Disease and Its Treatment on the Nervous System?

By Van Huynh, Leonard Sender and Daniela A. Bota

4104

Open access peer-reviewed

5. Treatment of Pediatric Acute Lymphoblastic Leukemia and Recent Advances

By Tai-Tsung Chang and Pei-Chin Lin

2786

Open access peer-reviewed

6. Cellular Therapy of ALL

By Casey A. Moffa, Cyrus Khan and John Lister

869

Open access peer-reviewed

7. Multidrug Resistance Mechanism of Acute Lymphoblastic Leukemia

By Zhaoliang Su, Haitao Zhu, Yanfang Liu, Hongyan Yuan, Jingping Yin and Huaxi Xu

1618

Open access peer-reviewed

8. Novel Therapeutic Targets in ALL Therapy

By Roman Crazzolara

958

Open access peer-reviewed

9. Aberrant Proliferative and Apoptotic Pathways in Acute Lymphoblastic Leukemia (ALL): Molecular Therapies to Overcome Chemo-Resistance

By Agostino Tafuri et, Michele Milella, Stefano Iacovelli, Fabiana De Cave, Chiara Gregorj, Paola Bergamo, Andrea Miele, Roberto Licchetta, Marina Konopleva, James A. McCubrey, Alberto M. Martelli, Robin Foà, Maria Teresa Petrucci and Maria Rosaria Ricciardi

1453

Open access peer-reviewed

10. The Role of PAX5 in ALL

By Grazia Fazio, Andrea Biondi and Giovanni Cazzaniga

2719

Open access peer-reviewed

11. p53 as a Therapeutic Target in T-ALL

By Irene Riz, Wenjing Yang, Weiqun Peng and Robert G. Hawley

755

Edited Volume and chapters are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Edited Volume

Free shipping with DHL Express

Hardcover (ex. VAT)£140

Order now

Residents of European Union countries need to add a Book Value-Added Tax of 5%. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase